Chronix Biomedical Company
Chronix Biomedical is a molecular diagnostics company developing blood tests for monitoring minimal residual disease in cancer patients.
Founded Date:
01.01.1997
Total Funding:
$21.5M
Investor Type:
N/A
Employee Number:
1-10
Investment Stage:
N/A
Funding Status:
M&A
Number Of Exists:
N/A
Technology:
Сancer Diagnostics
Last Funding Type:
Venture - Series Unknown
Investors Number:
3
Industry:
Deep Diagnostics
Headquarters:
San Jose, California, United States
Estimated Revenue:
$10M to $50M